Purdue Pharma’s Sackler Family Opioid Deal in Jeopardy

Purdue Pharma’s Sackler Family Opioid Deal in...

Up next

LtCOL. Karen Kwiatkowski : The Cost of Genocide

LtCOL. Karen Kwiatkowski : The Cost of GenocideSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info. 

Matt Hoh : What’s Wrong With the Navy?

Matt Hoh : What’s Wrong With the Navy?See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info. 

Recommended Episodes

Opioid Victims Have a Settlement. Will the Supreme Court Undo It?
The Daily

The opioid epidemic has been one of the biggest public health disasters in generations. The drug company at the heart of the crisis, Purdue Pharma, maker of the prescription painkiller OxyContin, agreed to a multibillion-dollar deal to settle thousands of claims against it — b ...

  Show more

Will Big Pharma Ever Face Justice for the Opioid Crisis?
The Daily Show: Ears Edition

The Supreme Court recently blocked a bankruptcy deal that would have given full immunity to the members of the Sackler family who once controlled Purdue Pharma, the maker of OxyContin. Trevor Noah calls out the frustrating contradictions within the initial deal and shares his tho ...  Show more

Ep. 217: Discovery Debacle At Arnold & Porter
Law360's Pro Say - News & Analysis on Law and the Legal Industry

Endo Pharmaceuticals and its attorneys at Arnold & Porter are facing accusations of serious discovery misconduct during opioid litigation across the country, threatening the company with huge liability and the lawyers with reputational damage. On this week’s show, we break down t ...  Show more

Bloomberg Markets: Perdue Faces Probe Over Opioid Marketing
Bloomberg Businessweek

Bloomberg Markets with Carol Massar and Cory Johnson.\u0010\u0010GUEST:\u0010Esmé Deprez\u0010Projects and Investigations Reporter\u0010Bloomberg News\u0010Discussing Federal prosecutors in Connecticut began a criminal investigation into Purdue Pharma Inc.’s marketing of the c ...

  Show more